A Research Study Comparing How Well Different Doses of the Medicine NN0519-0130 Lower Blood Sugar in People With Type 2 Diabetes

NCT06326047 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

299

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG: NNC0519-0130
DRUG: Placebo
DRUG: Trizepatide

Sponsor

Novo Nordisk A/S